Empowered Funds Portfolio holdings
Empowered Funds, which does business as ETF Architect, offers a ready-made ETF platform for fund managers, advisers and family offices, and runs its own ETFs on the same platform. Its specialty is tax-free exchanges, which it has used to move managed accounts, hedge funds and mutual funds into ETFs. The firm began operating as an investment adviser in 2014 and is wholly owned by Alpha Architect, which was founded by Wesley Gray, a former finance professor at Drexel University.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$170M |
| 2 |
NVIDIA
NVDA
|
+$124M |
| 3 |
Amazon
AMZN
|
+$89.6M |
| 4 |
Apple
AAPL
|
+$76.8M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$70.3M |
| 2 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$62.3M |
| 3 |
Roku
ROKU
|
+$36.8M |
| 4 |
TSMC
TSM
|
+$29.3M |
| 5 |
Citigroup
C
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.88% |
| 2 | Financials | 12.13% |
| 3 | Miscellaneous | 9.74% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2426
Gain Therapeutics
GANX
$46.3M
| $90.4K | ﹤0.01% |
+52,238
| New | +$95.3K |
2026 Q3
0 quarters
|
|
2427
SelectQuote
SLQT
$79.3M
| $89.7K | ﹤0.01% |
221,568
-70,000
| -24% | -$44.7K |
2026 Q1
2 quarters
|
|
2428
MAIA Biotechnology
MAIA
$61.8M
| $88.2K | ﹤0.01% |
+74,757
| New | +$101K |
2026 Q3
0 quarters
|
|
2429
Pliant Therapeutics
PLRX
$43.2M
| $87.4K | ﹤0.01% |
+80,893
| New | +$89.7K |
2026 Q3
0 quarters
|
|
2430
Xerox Holdings Corp Warrants
XRXDW
$9.2M
| $87.3K | ﹤0.01% |
316,498
| – | – |
2026 Q1
2 quarters
|
|
2431
Good Times Restaurants
GTIM
$13.4M
| $86.6K | ﹤0.01% |
57,737
| – | – |
2026 Q1
2 quarters
|
|
2432
Atlantic American Corp
AAME
$25.7M
| $85.1K | ﹤0.01% |
+64,928
| New | +$95.1K |
2026 Q3
0 quarters
|
|
2433
MediciNova
MNOV
$68.9M
| $82.8K | ﹤0.01% |
+49,430
| New | +$81.3K |
2026 Q3
0 quarters
|
|
2434
Humacyte
HUMA
$155M
| $81.5K | ﹤0.01% |
+157,378
| New | +$101K |
2026 Q3
0 quarters
|
|
2435
Invivyd
IVVD
$172M
| $79.9K | ﹤0.01% |
+91,849
| New | +$72.7K |
2026 Q3
0 quarters
|
|
2436
Kandi Technologies Group
KNDI
$34.6M
| $78.4K | ﹤0.01% |
9,931
| – | – |
2023 Q2
13 quarters
|
|
2437
Great Elm Group
GEG
$66.6M
| $78.4K | ﹤0.01% |
+36,473
| New | +$79.3K |
2026 Q3
0 quarters
|
|
2438
Tecogen Inc
TGEN
$57.7M
| $78.2K | ﹤0.01% |
+27,548
| New | +$95.5K |
2026 Q3
0 quarters
|
|
2439
Hyperfine
HYPR
$66.8M
| $77.7K | ﹤0.01% |
+96,214
| New | +$88.6K |
2026 Q3
0 quarters
|
|
2440
Barnwell Industries
BRN
$12.5M
| $77.6K | ﹤0.01% |
84,312
+34,368
| +69% | +$34.2K |
2026 Q1
2 quarters
|
|
2441
Spero Therapeutics
SPRO
$58.2M
| $77.1K | ﹤0.01% |
+63,741
| New | +$86.5K |
2026 Q3
0 quarters
|
|
2442
SCYNEXIS
SCYX
$31.9M
| $76.4K | ﹤0.01% |
15,462
| – | – |
2026 Q1
2 quarters
|
|
2443
Zedge
ZDGE
$43.8M
| $76.3K | ﹤0.01% |
+26,506
| New | +$79.5K |
2026 Q3
0 quarters
|
|
2444
T1 Energy
TE
$572M
| $75.9K | ﹤0.01% |
+19,651
| New | +$101K |
2026 Q3
0 quarters
|
|
2445
iHeartMedia
IHRT
$92.5M
| $75.1K | ﹤0.01% |
+35,769
| New | +$114K |
2026 Q3
0 quarters
|
|
2446
Outset Medical
OM
$70.4M
| $73.7K | ﹤0.01% |
+24,581
| New | +$100K |
2026 Q3
0 quarters
|
|
2447
Aurora
AUR
$8.51B
| $71.1K | ﹤0.01% |
+12,840
| New | +$80.8K |
2026 Q3
0 quarters
|
|
2448
OS Therapies Inc
OSTX
$34.9M
| $70.8K | ﹤0.01% |
+44,238
| New | +$72.4K |
2026 Q3
0 quarters
|
|
2449
Vivid Seats
SEAT
$15.6M
| $70.2K | ﹤0.01% |
+18,194
| New | +$116K |
2026 Q3
0 quarters
|
|
2450
MaxCyte
MXCT
$123M
| $66.5K | ﹤0.01% |
+59,368
| New | +$72.8K |
2026 Q3
0 quarters
|
|
Similar funds
Empowered Funds's Q3 2026 Portfolio in Review
As of Q3 2026, Empowered Funds held 2,696 positions worth $21.7B, up 14% from $19B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Empowered Funds deployed $2.79B of net new capital in Q3 2026, opening 584 new positions and adding to 1,313 existing holdings. Its largest new stake was SK Hynix Inc: 193,851 shares worth $35.7M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was Roku, an estimated $36.8M trimmed.
- Empowered Funds's largest Q3 2026 buy was SK Hynix Inc: 193,851 shares worth $35.7M.
- Empowered Funds added most to Microsoft in Q3 2026, an estimated $170M increase.
- Empowered Funds's biggest Q3 2026 reduction was Roku, cutting an estimated $36.8M.
- Empowered Funds fully exited Schwab Intermediately-Term US Treasury ETF in Q3 2026, selling an estimated $70.3M.
- Empowered Funds's ten largest holdings make up 19% of its $21.7B portfolio in Q3 2026.
- Empowered Funds opened 584 new positions and closed 184 in Q3 2026.
- Empowered Funds's portfolio value rose 14% quarter-over-quarter to $21.7B.
Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.